Table 1: Clinicopathological characteristics of 130 PCa patients treated with radical prostatectomy.
|
Variables |
Total N = 130 (%) |
|
Median age, years (range) |
(130) 62.0 (49-77) |
|
cT stage T1 T2A T2B T3 T4 Tx |
11 (8.5) 14 (10.8) 57 (43.8) 37 (28.5) 10 (7.7) 1 (0.8) |
|
pT stage pT1 pT2 pT3 pT4 |
12 (9.2) 71 (54.6) 38 (29.2) 9 (6.9) |
|
Histological grade AJCC 1 2-3 4-5 |
69 (53.1) 49 (37.7) 12 (9.2) |
|
Gleason Score ≤ 6 7 ≥ 8 |
67 (51.5) 50 (38.5) 13 (10.0) |
|
Radicality of surgery Yes No |
85 (65.4) 45 (34.6) |
|
Hist-pat surgical margins Negative Positive |
71 (54.6) 59 (45.4) |
|
Seminal vesicle(s) invasion Negative Positive |
107 (82.3) 23 (17.7) |
|
Adjuvant treatment None Radiotherapy (RT) Hormontherapy (H) RT + H RT + H + chemotherapy (CHT) antiLH-RHa LH-RH + RT |
77 (59.2) 26 (20.0) 11 (8.5) 12 (9.2) 2 (1.5) 1 (0.8) 1 (0.8) |
|
Follow-up time (months) Median (range) |
79.0 (1 – 148) |
|
Local recurrences Median time, months (range) Metastases Median time (range) |
12 (9.2) 29 (5-92) 13 (10.0) 46 (11-88) |
aLuteinizing hormone-releasing hormone.